New York State Common Retirement Fund’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151M | Sell |
|
|||||
|
2025
Q1 | $168M | Sell |
|
|||||
|
2024
Q4 | $146M | Buy |
|
|||||
|
2024
Q3 | $167M | Sell |
|
|||||
|
2024
Q2 | $182M | Sell |
|
|||||
|
2024
Q1 | $164M | Sell |
|
|||||
|
2023
Q4 | $166M | Sell |
|
|||||
|
2023
Q3 | $154M | Sell |
|
|||||
|
2023
Q2 | $165M | Buy |
|
|||||
|
2023
Q1 | $146M | Sell |
|
|||||
|
2022
Q4 | $137M | Buy |
|
|||||
|
2022
Q3 | $136M | Sell |
|
|||||
|
2022
Q2 | $138M | Buy |
|
|||||
|
2022
Q1 | $127M | Sell |
|
|||||
|
2021
Q4 | $108M | Sell |
|
|||||
|
2021
Q3 | $91.3M | Buy |
|
|||||
|
2021
Q2 | $100M | Buy |
|
|||||
|
2021
Q1 | $106M | Sell |
|
|||||
|
2020
Q4 | $121M | Sell |
|
|||||
|
2020
Q3 | $147M | Sell |
|
|||||
|
2020
Q2 | $164M | Sell |
|
|||||
|
2020
Q1 | $135M | Sell |
|
|||||
|
2019
Q4 | $125M | Sell |
|
|||||
|
2019
Q3 | $98.5M | Buy |
|
|||||
|
2019
Q2 | $106M | Sell |
|
|||||
|
2019
Q1 | $121M | Sell |
|
|||||
|
2018
Q4 | $118M | Sell |
|
|||||
|
2018
Q3 | $146M | Sell |
|
|||||
|
2018
Q2 | $132M | Sell |
|
|||||
|
2018
Q1 | $130M | Sell |
|
|||||
|
2017
Q4 | $126M | Buy |
|
|||||
|
2017
Q3 | $125M | Buy |
|
|||||
|
2017
Q2 | $102M | Buy |
|
|||||
|
2017
Q1 | $82.1M | Sell |
|
|||||
|
2016
Q4 | $56.2M | Buy |
|
|||||
|
2016
Q3 | $66.3M | Buy |
|
|||||
|
2016
Q2 | $65.2M | Buy |
|
|||||
|
2016
Q1 | $55.5M | Buy |
|
|||||
|
2015
Q4 | $79.2M | Sell |
|
|||||
|
2015
Q3 | $67.9M | Buy |
|
|||||
|
2015
Q2 | $80.1M | Sell |
|
|||||
|
2015
Q1 | $77.6M | Buy |
|
|||||
|
2014
Q4 | $77.7M | Sell |
|
|||||
|
2014
Q3 | $78.4M | Sell |
|
|||||
|
2014
Q2 | $67.7M | Sell |
|
|||||
|
2014
Q1 | $52.2M | Hold |
|
|||||
|
2013
Q4 | $54.8M | Sell |
|
|||||
|
2013
Q3 | $63.2M | Buy |
|
|||||
|
2013
Q2 | $56M | Buy |
|